Semaglutide Shortage Timeline and History
Pharmaceutical availability gaps remain a burden on people across the country. We’re sharing up-to-date tracking on availability and alternatives.
Stock Status
As of October 2026, supply conditions for these drugs varies significantly by:
- Product and dosage: Lower starter doses are typically in better supply than target doses
- Where you live: Supply chains favor high-volume markets while rural areas face more difficulty
- Pharmacy type: Mail-order options sometimes have what chain pharmacies can’t get
Dose-Specific Tracking
Beginning Doses
Initial titration products are generally more available because:
- Less demand remains on starting strength permanently
- Manufacturers prioritize initial supply to guarantee new patient access
Higher Dosing
Target dosing face more pressure because:
- Established patients end up on higher doses and remain
- Production can’t keep up the cumulative patient load
If You’re Affected
Right Now
- Call ahead — never drive to any location without confirming availability
- Try multiple locations — call at least 5 locations including independent ones
- Ask about waiting lists — certain stores will call when stock arrives
Extended Supply Issues
- Talk to your prescriber about temporary changes — they may prescribe an alternative approach
- Explore compounded alternatives — should your prescription be on the FDA shortage list, custom formulations can be prescribed
- Contact the drug maker — pharma companies offer services to assist with access
Monitoring Resources
Use these resources to track availability:
- FDA.gov shortage page — the official record
- Drug maker supply pages — production news published by the manufacturers
- Your pharmacy app — may display whether it’s in stock
- Support groups — community members report live where they found it
This page is updated when new information becomes available.